A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy Volunteers
Clinical trial NCT01818024 · COMPLETED
Trial details
- NCT number
- NCT01818024
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-22
- Primary completion
- 2013-10-25
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.